BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6614939)

  • 21. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
    Takeyama H; Yano K; Kataoka T; Watanabe E; Kobayashi M; Ohno R
    Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasma concentration of alpha-interferon following continuous subcutaneous infusion].
    Tari K; Tsujii T; Yonese J
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2159-61. PubMed ID: 3395139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
    Furue H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of human lymphoblastoid interferon (HLBI) on the growth of 2 human malignant melanoma xenografts in nude mice].
    Hashizume S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1296-302. PubMed ID: 6732256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of condyloma acuminata using human lymphoblastoid interferon].
    Kinukawa T; Hattori R; Furukawa T; Ohshima S; Matsuura O; Takeuchi N; Tanaka K; Hashimoto J; Ono Y; Watanabe J
    Hinyokika Kiyo; 1990 Nov; 36(11):1295-300. PubMed ID: 2288309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia].
    Ichimaru M; Kamihira S; Moriuchi Y; Kuraishi Y; Usui N; Toki H; Okabe K; Niho Y; Shibuya T; Umei T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2975-81. PubMed ID: 3052302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.
    Martínez R; Vaquero J; Ramiro J; García Salazar F; De Oya S
    Acta Neurochir (Wien); 1989; 100(1-2):46-9. PubMed ID: 2554692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T; Laszlo J; Moore J; Silverman P
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of multiple myeloma with recombinant interferon alfa-2a.
    Ohno R; Kimura K
    Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
    Ezaki K
    Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical study of renal cell carcinoma].
    Yamada Y; Fukatsu H; Honda N; Miyagawa Y; Segawa A
    Hinyokika Kiyo; 1993 Dec; 39(12):1197-203. PubMed ID: 7506869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
    Imamura Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
    Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current status and problems of cancer treatment with interferon].
    Ichikawa H
    Gan No Rinsho; 1983 May; 29(6):616-9. PubMed ID: 6876430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice.
    Yamaoka T; Takada H; Yanagi Y; Kataoka T; Sakurai Y
    Cancer Chemother Pharmacol; 1985; 14(3):184-7. PubMed ID: 3995680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human lymphoblastoid interferon therapy for advanced renal cell carcinoma.
    Marumo K; Murai M; Hayakawa M; Tazaki H
    Urology; 1984 Dec; 24(6):567-71. PubMed ID: 6506397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
    Kanno H; Kitami K; Senga Y; Takahashi T; Nagashima Y
    Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.